ZYNE
ZYNE Real Time Price USDRecent trades of ZYNE by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ZYNE's directors and management
Government lobbying spending instances
-
$45,000 Oct 04, 2023 Issue: Pharmacy Government Issues Health Issues
-
$45,000 Jul 18, 2023 Issue: Pharmacy Government Issues Health Issues
-
$15,000 Jan 09, 2023 Issue: Pharmacy Government Issues Health Issues
-
$15,000 Oct 12, 2022 Issue: Pharmacy Government Issues Health Issues
-
$20,000 Jul 13, 2022 Issue: Pharmacy Government Issues Health Issues
-
$30,000 Apr 19, 2022 Issue: Pharmacy Government Issues Health Issues
-
$30,000 Jan 10, 2022 Issue: Pharmacy Government Issues Health Issues
-
$45,000 Oct 18, 2021 Issue: Pharmacy Health Issues Government Issues
-
$45,000 Jul 08, 2021 Issue: Pharmacy Government Issues Health Issues
-
$45,000 Apr 19, 2021 Issue: Health Issues Government Issues Pharmacy
-
$45,000 Jan 08, 2021 Issue: Pharmacy Health Issues Government Issues
-
$10,000 Oct 22, 2018 Issue: Pharmacy Medical/Disease Research/Clinical Labs
-
$20,000 Jan 19, 2017 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
-
$20,000 Oct 20, 2016 Issue: Budget/Appropriations
-
$20,000 Jul 20, 2016 Issue: Budget/Appropriations
-
$10,000 Oct 20, 2015 Issue: Medical/Disease Research/Clinical Labs Pharmacy
-
$60,000 Jul 20, 2015 Issue: Pharmacy Medical/Disease Research/Clinical Labs
-
$50,000 Apr 20, 2015 Issue: Pharmacy Medical/Disease Research/Clinical Labs
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of ZYNE in WallStreetBets Daily Discussion
Recent insights relating to ZYNE
Recent picks made for ZYNE stock on CNBC
ETFs with the largest estimated holdings in ZYNE
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ZYNE Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.